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Abstract
Background: Previous work has suggested that in the liver, adenosine preconditioning is mediated
by nitric oxide. Whether the endothelial isoform of nitric oxide synthase plays a part in this
mechanism has however not yet been investigated.
Methods: Wistar rats were used (6 in each group) – Groups: (1) sham, (2) ischemia-reperfusion,
(3) adenosine + ischemia-reperfusion, (4) endothelial isoform inhibitor + adenosine + ischemia-
reperfusion.
Results: Using immunohistochemistry, this study has revealed a decrease in the expression of
endothelial nitric oxide synthase following hepatic ischemia-reperfusion. This was prevented by
adenosine pre-treatment. When an inhibitor of endothelial nitric oxide synthase was administered
prior to adenosine pre-treatment, pre-conditioning did not occur despite normal expression of
endothelial nitric oxide synthase.
Conclusions: These findings suggest that adenosine attenuates hepatic injury by preventing the
downregulation of endothelial nitric oxide synthase that occurs during ischemia-reperfusion.
Background
Hepatic surgery may be complicated by liver failure. This
is usually a result of poor hepatic reserve and reperfusion
injury [1]. The latter is partly due to failure of the hepatic
microcirculation. Sinusoidal and Kupffer cell swelling fol-
lowing depletion of adenosine 5'-triphosphate during the
ischemic period, increased production of the potent vaso-
constrictor endothelin and possibly decreased production
of nitric oxide (NO), all contribute to narrowing of the si-
nusoidal lumen [2].
Nitric oxide (NO), a hydrophobic gaseous molecule, is
synthesised from L-arginine by different isoforms of nitric
oxide synthase (NOS). Two principal forms of NOS have
been described – a constitutive/endothelial form (eNOS)
and an inducible form expressed by a number of cells,
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usually in response to inflammatory mediators. The prop-
erties of NO appear to depend on which isoform has con-
tributed to its formation. eNOS, a 135-kDa protein, is
dependent on intracellular calcium levels for its activity. It
produces a basal level of NO that acts as a vasodilator [3].
Preconditioning refers to a phenomenon in which tissues
are rendered resistant to the deleterious effects of
ischemia-reperfusion (I-R), either by previous exposure to
brief periods of vascular occlusion (ischemic precondi-
tioning) or by the administration of certain chemical
agents (pharmacological preconditioning). Of the latter,
exogenous adenosine is the most studied and it has been
shown to attenuate hepatic reperfusion injury [4–8]. Ad-
ministration of non-specific inhibitors of NOS reverses
this protective effect [4–6]. Adenosine may thus prevent
the decrease in NO production believed to occur during
early reperfusion. The present study was therefore de-
signed to investigate the effect of exogenous adenosine on
eNOS expression during hepatic reperfusion.
Methods
The study was performed using male Wistar rats (6 for
each group) weighing 250–300 g. All animals (including
controls) were anaesthetised by intraperitoneal adminis-
tration of 2.7 ml/kg of a mixture of one part midazolam +
one part Hypnorm ((1 ml of Hypnorm contains 10 mg
fluanisone and 0.315 mg fentanyl citrate)) + two parts
sterile water. The rats were placed supine on a heating pad
to maintain body temperature between 36.5C and
37.5C throughout the procedure. The carotid artery was
cannulated using an intravenous cannula (Portex, Hythe,
UK, 20 G/32 mm) to allow for continuous blood pressure
monitoring (Device Mx2, Lectromed UK, Letchworth,
UK) and the infusion of normal saline at 0.5 ml/h. All an-
imals underwent laparotomy. The left lateral and median
lobes of the liver were mobilised and delivered through
the incision after dividing their suspensory ligaments. An
avascular plane was developed between the ventral sur-
face of the liver and the portal vein and hepatic artery sup-
plying these lobes. To induce hepatic ischemia, an
atraumatic microvascular clip was applied to occlude the
portal vein and hepatic artery just distal to the branches
supplying the right lateral lobe for 45 min. After 6 h of
reperfusion in the I-R groups, and in the control groups a
time period equivalent to the duration of ischemia and
reperfusion, blood (0.5 ml) was withdrawn from the arte-
rial cannula for the measurement of liver enzymes. The
left lateral and median lobes of the liver were harvested
and divided for histological paraffin wax examination and
immunohistochemical staining. All animal experimental
procedures were carried out in accordance with UK Gov-
ernment legislation (Project Licence Number: 70/4393).
To study whether adenosine could modulate NOS expres-
sion in hepatic I-R, the following experimental groups
were set up:
Group 1 animals subjected to anaesthesia and sham
laparotomy only;
Group 2 animals subjected to 45 minutes of partial hepat-
ic ischemia (as described above), followed by 6 h of reper-
fusion;
Group 3 animals subjected to hepatic ischemia (as de-
scribed in Group 2), were pre-treated with adenosine (1
mg/kg) dissolved in bicarbonate-buffered saline (pH 7.4)
administered via the carotid artery cannula over a 20
minute period. (Animals enrolled in a group not ran-
domised to receive adenosine were given an equivalent
volume of buffer solution at the corresponding time peri-
od). Hepatic ischemia was induced immediately follow-
ing the termination of the adenosine infusion.
Group 4 animals treated with adenosine and subjected to
hepatic ischemia (as described in Group 3) were also
treated with the relative eNOS inhibitor NG-Nitro-L-ar-
ginine (L-NA). This was administered via the carotid can-
nula at a dose of 10 mg/kg, 3 minutes prior to the
administration of adenosine. (Animals in all the other
groups received an equivalent volume of buffer solution
at the corresponding time period).
Liver transaminases
Heparinised blood samples from each rat were immedi-
ately centrifuged at 2,000 g for 10 minutes and the super-
natant plasma was stored at -20C. Aspartate and alanine
transaminase levels in plasma were later measured in a
clinical chemistry laboratory at Hammersmith Hospital,
London, UK, using an Olympus AU600 Analyser (Olym-
pus Optical Co Ltd, Tokyo, Japan), as markers of hepato-
cellular injury.
H&E staining
Liver sections from each animal were fixed in 10% neutral
buffered formalin, dehydrated by passage through graded
ethanol series, cleared in xylene and embedded in paraffin
blocks. The blocks were 4-m sectioned and stained with
hematoxylin and eosin, according to standard protocols.
Sections were evaluated using light microscopy by a blind-
ed member of our research team.
Immunohistochemistry
Liver sections from each animal were fixed in 1% parafor-
maldehyde in phosphate buffered saline (PBS) for four
hours and then transferred into a storage buffer, PBS/su-
crose, at 4C until the cryostat blocks were prepared. Tis-
sue sections (4 m) were cut on a cryostat and applied toBMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/22
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Figure 1
Bar graphs demonstrating the geometric mean and 95% confidence interval for plasma aspartate transaminase and plasma
alanine transaminase in each group. [Sham – Group 1 (sham laparotomy); IR only – Group 2 (ischemiareperfusion without
prior adenosine therapy); A+IR – Group 3 (ischemiareperfusion with prior adenosine pre-treatment); L-NA+A+IR – Group 4
(ischemiareperfusion with administration of the eNOS inhibitor NG-Nitro-L-arginine prior to adenosine preconditioning).
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slides. The avidin-biotin complex immunoperoxidase
staining system was used. The primary antibody, anti-
eNOS monoclonal, was produced in mice and was ob-
tained from Affiniti Research Products Ltd, Exeter UK. The
presence of positive staining with the specific antibody
was indicated by the development of a reddish-brown
stain in the section, as a consequence of using the 3,3'-di-
amino-benzidine substrate. Each section was reviewed by
a blinded member of the research team who noted the
presence or absence of staining and its cellular location.
Statistics
The liver enzyme data were log transformed to satisfy the
assumptions required to perform parametric tests and are
therefore presented as geometric mean and 95% confi-
dence intervals of the mean. Orthogonal contrasts in
ANOVA were then used to analyse statistically the differ-
ence between any two specified groups.
Results
Liver Transaminases (see figure 1)
The concentrations of plasma liver transaminases be-
tween the different groups were significantly different at 6
h following the onset of reperfusion (p < 0.001 using
ANOVA following logarithmic transformation). Both as-
partate and alanine transaminase plasma levels were
markedly higher in Group 2 (I-R only) when compared to
Group 1 (sham laparotomy) (p < 0.001). The administra-
tion of adenosine just prior to the onset of ischemia in
Group 3 significantly attenuated the rise in liver enzymes
(p < 0.001 for both transaminases when compared with
the I-R group). In Group 4, administration of L-NA prior
to adenosine pre-treatment resulted in an increase in plas-
ma liver transaminases similar to that seen in the I-R
group (p > 0.5 for both transaminases).
H&E staining
On routine histology, liver sections from all the animals
in Group 1 (sham) revealed a normal hepatic architecture
with no evidence of hepatocyte necrosis. Partial hepatic
ischemia followed by reperfusion in Group 2 animals re-
sulted in moderate hepatic injury. This was visualised mi-
croscopically as centrilobular hepatocyte necrosis, mitotic
figures, trabecular derangement and polymorphonuclear
cell infiltrate. In liver sections from rats in Group 3 (A + I-
R), there was no evidence of hepatocyte injury except for
the occasional appearance of isolated necrotic hepato-
cytes. Sections from Group 4 (L-NA + A + I-R) were similar
to those from Group 2 (I-R only).
Immunohistochemistry (see figure 2)
In all liver samples from Group 1 (sham), staining with
the anti-eNOS antibody revealed pronounced staining of
all the endothelial cells, i.e. both those lining the blood
vessels and the sinusoids. In all specimens from Group 2
(I-R only) staining of sinusoidal endothelial cells in the
centrilobular region was absent whilst staining of en-
dothelial cells lining blood vessels and sinusoids in the
periphery of the lobule was much less intense than in
samples from control animals. Liver sections from all
those animals receiving adenosine prior to I-R (Group 3
and 4) had a distribution and intensity of staining with
Figure 2
Liver sections, representative of each group, stained with anti-eNOS antibody. Sham and A+IR – very strong staining of sinusoi-
dal endothelial cells; IR only – absence of staining of sinusoidal endothelial cells. [a. Sham – Group 1 (sham laparotomy); b. IR
only – Group 2 (ischemia-reperfusion without prior adenosine administration); c. A+IR – Group 3 (ischemia-reperfusion with
prior adenosine pre-treatment).]BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/22
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eNOS antibody similar to that in the livers from the con-
trol group.
Discussion
The current study has shown that 45 minutes of hepatic
ischemia followed by 6 h of reperfusion result in consid-
erable hepatic injury as evidenced by microscopic changes
in the liver architecture and release of transaminases. This
was associated with a decrease in the normal expression of
eNOS within the sinusoidal endothelial cells. This is con-
sistent with previous work suggesting that NO production
during the immediate reperfusion period is decreased.
Ohmori et al have shown that the administration of NO
donors attenuates early hepatic reperfusion injury [9].
In keeping with previous reports from Peralta et al [4,5],
these changes were largely prevented by the administra-
tion of systemic adenosine prior to the ischemic period.
The experimental model in this study, however, differed
slightly from that used by the Barcelona group in two
main aspects. The left lateral and median lobes, which ac-
count for 70% of the rat's liver mass, were rendered
ischemic as opposed to the right hepatic lobe (30% of liv-
er mass). The current model is therefore more similar to
the clinical situation where the whole liver is rendered
ischemic during total vascular exclusion (which is not tol-
erated in the rat) for liver resections. Outcome measures
(hepatic transaminases and histology) were determined at
6 h from the onset of reperfusion as opposed to 90 min-
utes, since a number of mechanisms, such as neutrophil
activation, which contribute to hepatic injury are opera-
tive by 6 h but not by 90 minutes [2].
The findings in this study support previous reports that in
models of hepatic I-R the protective effect of adenosine
seems to be mediated by NO [4,5]. NO is not solely a
smooth muscle relaxant. In the last decade NO has been
shown to act as a potent anti-inflammatory agent, inhib-
iting the expression of pro-inflammatory genes [10,11].
This may partly account for its important role in hepatic I-
R. We believe that basal production of NO from endog-
enously expressed eNOS in the sinusoidal cells of the liver
may exert an inhibitory effect on the activation of pro-in-
flammatory transcription factors. During the no-reflow
period, downregulation of eNOS results in subnormal
NO concentrations. This may lead to activation of pro-in-
flammatory genes with the subsequent expression of pro-
inflammatory cytokines, chemokines and cellular adhe-
sion molecules, all of which are involved in the pathogen-
esis of hepatic reperfusion injury.
Using immunohistochemical techniques, the current
study has revealed that adenosine prevents the downregu-
lation of eNOS. To evaluate whether this finding is part of
the mechanism by which adenosine attenuates hepatic I-
R injury, a relative eNOS inhibitor was administered prior
to adenosine to verify whether the prevention of eNOS
downregulation was implicated in this protective mecha-
nism. Despite normal expression of eNOS, the rise in liver
enzymes in those animals administered an eNOS inhibi-
tor prior to adenosine was similar to that of those animals
not receiving adenosine preconditioning, supporting the
hypothesis that the protective effect of adenosine in he-
patic I-R is a result of the prevention of eNOS downregu-
lation. We think that adenosine, by preventing the
downregulation of eNOS, may prevent the cascade of
events resulting from activation of pro-inflammatory nu-
clear transcription factors, thereby exerting its protective
effect. In keeping with this hypothesis, recent experimen-
tal work has shown that adenosine prevents the activation
of a potent pro-inflammatory nuclear transcription factor
when administered prior to cardiac ischemia-reperfusion
[12].
Further work is required to study the mechanisms by
which adenosine prevents the downregulation of eNOS.
Adenosine is a major component of vascular homeostasis,
playing an important role in regulating smooth muscle
tone acting via cAMP-mediated cascades to induce vascu-
lar smooth muscle relaxation [13]. Evidence is accumulat-
ing that eNOS expression is regulated in response to shear
stress via poorly understood mechanisms [14]. We there-
fore infer that by altering blood flow through the sinu-
soids, adenosine may thus, indirectly alter eNOS
expression.
This study has shed more light on a mechanism by which
hepatic reperfusion injury may be attenuated. By prevent-
ing the downregulation of eNOS within the hepatic sinu-
soidal cells, adenosine has been shown to act as a potent
preconditioning agent.
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